Papaverine

Generic Name
Papaverine
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C20H21NO4
CAS Number
58-74-2
Unique Ingredient Identifier
DAA13NKG2Q
Background

An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosph...

Indication

For the treatment of impotence and vasospasms.

Associated Conditions
Vascular spasm, Visceral spasms
Associated Therapies
-

IV PAPAVERINE Prior to Propess for Labor Induction

Phase 4
Not yet recruiting
Conditions
Interventions
First Posted Date
2024-08-12
Last Posted Date
2024-08-12
Lead Sponsor
Western Galilee Hospital-Nahariya
Target Recruit Count
110
Registration Number
NCT06550232

Papaverine and Oxytocin vs Oxytocin Alone in Labor Induction

First Posted Date
2024-08-09
Last Posted Date
2024-08-09
Lead Sponsor
Western Galilee Hospital-Nahariya
Target Recruit Count
126
Registration Number
NCT06547437

Effect of Papaverine on Renal Artery Blood Flow Volume

Phase 4
Completed
Conditions
Interventions
First Posted Date
2019-11-14
Last Posted Date
2021-04-19
Lead Sponsor
Asan Medical Center
Target Recruit Count
96
Registration Number
NCT04162834
Locations
🇰🇷

Asan medical Center, Seoul, Korea, Republic of

The Effect of Periradial Injection of Papaverine Versus Nitroglycerine on Radial Artery Diameter

First Posted Date
2019-07-24
Last Posted Date
2020-09-16
Lead Sponsor
Kasr El Aini Hospital
Target Recruit Count
90
Registration Number
NCT04030663
Locations
🇪🇬

Faculty of Medicine, Cairo, Benisuef, Egypt

Papaverine vs Heparin for Peripheral Arterial Catheter Patency in Pediatric Patients

First Posted Date
2019-03-29
Last Posted Date
2022-10-27
Lead Sponsor
The University of Texas Health Science Center, Houston
Target Recruit Count
100
Registration Number
NCT03894904
Locations
🇺🇸

UT Health, Houston, Texas, United States

Prostatic Hyperplasia Treatment and Cancer Prevention

Early Phase 1
Conditions
Interventions
First Posted Date
2017-02-27
Last Posted Date
2021-02-25
Lead Sponsor
Manchanda Medical Clinic
Target Recruit Count
40
Registration Number
NCT03064282

Optimal Analgesia in Acute Gastroenteritis

Phase 3
Terminated
Conditions
Interventions
First Posted Date
2016-03-17
Last Posted Date
2016-03-17
Lead Sponsor
Hadassah Medical Organization
Target Recruit Count
15
Registration Number
NCT02711241
Locations
🇮🇱

Hadssah Medical Organisation, Jerusalem, Israel

Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer

First Posted Date
2004-04-08
Last Posted Date
2012-07-30
Lead Sponsor
M.D. Anderson Cancer Center
Target Recruit Count
111
Registration Number
NCT00080808
Locations
🇺🇸

M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath